IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,807,574 | -8.2% | 1,496,170 | +42.1% | 0.04% | -4.8% |
| Q2 2023 | $7,412,564 | +10.7% | 1,052,921 | -3.9% | 0.04% | -6.7% |
| Q1 2023 | $6,693,132 | -10.1% | 1,095,439 | -6.0% | 0.04% | -27.4% |
| Q4 2022 | $7,448,810 | +25.7% | 1,165,698 | +88.4% | 0.06% | -1.6% |
| Q3 2022 | $5,927,000 | +16.7% | 618,685 | +34.5% | 0.06% | +34.0% |
| Q2 2022 | $5,079,000 | -24.8% | 460,080 | +13.4% | 0.05% | +17.5% |
| Q1 2022 | $6,755,000 | +23.9% | 405,708 | +42.1% | 0.04% | +37.9% |
| Q4 2021 | $5,450,000 | +61.5% | 285,506 | +108.6% | 0.03% | +26.1% |
| Q3 2021 | $3,375,000 | +16.6% | 136,857 | +23.0% | 0.02% | +27.8% |
| Q2 2021 | $2,894,000 | -4.8% | 111,235 | +15.8% | 0.02% | -14.3% |
| Q1 2021 | $3,041,000 | +251.2% | 96,049 | +414.6% | 0.02% | +162.5% |
| Q4 2020 | $866,000 | -58.0% | 18,663 | -70.2% | 0.01% | -68.0% |
| Q3 2020 | $2,061,000 | +132.1% | 62,592 | +93.4% | 0.02% | +92.3% |
| Q2 2020 | $888,000 | +144.6% | 32,365 | +166.9% | 0.01% | -13.3% |
| Q1 2020 | $363,000 | -87.3% | 12,128 | -88.2% | 0.02% | -65.9% |
| Q4 2019 | $2,851,000 | -35.2% | 102,990 | -57.4% | 0.04% | -36.2% |
| Q3 2019 | $4,398,000 | +86.1% | 241,660 | +150.7% | 0.07% | +64.3% |
| Q2 2019 | $2,363,000 | +67.4% | 96,386 | -35.1% | 0.04% | +82.6% |
| Q1 2019 | $1,412,000 | – | 148,437 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |